Clinical Trial

Coronary Microvascular Dysfunction Assessments in Myocardial Infarction With Non-Obstructive Coronary Arteries

Study acronym: CMD-MINOCA
Recruiting
View on ClinicalTrials.gov →
Summary
To compare clinical outcomes of myocardial infarction with non-obstructive coronary arteries (MINOCA) according to the coronary microvascular dysfunction (CMD), evaluated by optical coherence tomography (OCT), invasive and non-invasive coronary physiologic assessment.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-02-28; most recent amendment 2026-05-08.
Trial Details
NCT Number NCT05272618
Lead Sponsor Chonnam National University Hospital
Collaborators: Korean Cardiac Research Foundation, Abbott
Conditions Myocardial Infarction, Coronary Microvascular Dysfunction, Vasospasm, Coronary
Enrollment 150 participants
Start Date 2022-02-14
Primary Completion 2029-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-12